Public Comments to Agencies
CAGW submits comments to CMS reaffirming its opposition to its Most Favored Nation Policy
Most Favored Nation Policy implements destructive price controls, which destroy innovation and never solve the problem for which they were created.
CAGW Files Comments Regarding Use of Distributed Transmission System Technologies
On December 11, 2020, CAGW filed comments with the FCC urging the agency to hold off voting on a proposal that would allow for increased signals for Next Generation TV that could disrupt the use of TV white space technology for rural broadband...
CAGW Asks President to Halt the Most Favored Nation Policy
Using the MFN policy for pharmaceuticals is simply more price controls that will further distort the market and harm biopharmaceutical research.
CAGW Files Letter regarding Use of 12 GHz Spectrum Band
CAGW strongly urges the FCC to deny the April 26, 2016 petition request of the MVDDS 5G Coalition.
CAGW Comments to the NAIC Concerning Pharmacy Benefit Managers
CAGW writes comments to the National Association of Insurance Commissioners regarding draft model legislation concerning pharmacy benefit managers.
CAGW Comments to FCC on Declaratory Petition on Pole Attachments
Deploying broadband to unserved areas of the country has long been a top priority for the FCC.
CAGW Tells HHS to Reject State AGs Request to Steal Gilead’s Patent
CAGW urges the U.S. Department of Health & Human Services to not steal Gilead's patent, which was requested by state attorney generals.
Coalition Urges FCC to Grant the Petition of Charter Communications
A coalition of organizations filed comments with the FCC regarding data caps and usage pricing.
CAGW Supports a Consistent Cost-Benefit Analysis for the Clean Air Act
The EPA must ensure that the Clean Air Act rules proposed under the Advance Notice of Proposed Rulemaking must provide consistent and high quality cost-benefit analyses for significant rules.
Coalition Urges CMS to Oppose a Significant Regulatory Expansion of the Medicaid Drug Rebate Program
Coalitions urges CMS Admin to oppose regulatory expansion of the Medicaid Drug Rebate Program.
CAGW urges White House to Withdraw Proposed EOs regarding Foreign Reference Drug Pricing
CAGW asks the White House Chief of Staff to withdraw any proposed Executive Orders regarding foreign drug pricing.
CAGW Comments to the FERC on Net Metering
CAGW files comments in favor of New England Ratepayers Association's petition concerning wholesale energy sales.
